Patent · US Active

Gla domains as targeting agents

US9694048B2 · kind B2 · utility

3Cited by

0References

6Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Maxine Bauzon · Hercules, US
Terry Hermiston · Corte Madera, US

Key dates

Filing date	Mar 13, 2014
Grant date	Jul 4, 2017
Priority date	—
Expiry date	Mar 13, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates to the recombinant Gla domain proteins and their use targeting phosphatidylserine (PtdS) moieties on the surface of cells, particularly those expressing elevated levels of PtdS, such as cells undergoing apoptosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.